SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-053348
Filing Date
2022-10-11
Accepted
2022-10-11 16:55:45
Documents
2
Period of Report
2022-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 6847
2 EX-24 DOCUMENT attachment1.htm EX-24 4242
  Complete submission text file 0001209191-22-053348.txt   12545
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Chee Conley (Reporting) CIK: 0001883804 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37813 | Film No.: 221304615